SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] DEF 14A:
[]
SKBI [SKYSTAR BIO-PHARMACEUTICAL] DEF 14A: Skystar Bio-Pharmaceuticalmpany Notice of Annual Meeting and Proxy
[Skystar Bio-Pharmaceuticalmpany Notice of Annual Meeting and Proxy Statement Annual Meeting to be held on October 25, 2013, at 4/F Building B Chuangye Square, No. 48 Keji Road, Gaoxin District, Xian, Shaanxi Province, P.R. China, at 7:45 pm, local timeYSTAR BIO-PHARMACEUTICALMPANY 4/F Building B Chuangye Square, No. 48 Keji Road,Gaoxin District, Xian, Shaanxi Province, P.R.]
RCON [Recon Technology] 10-K:
[] [I, Yin Shenping, certify that:] [Certification of Principal Financial Officer I, Liu Jia, certify that:] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Yin Shenping] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Liu Jia Chief Financial Officer (Principal Financial Officer)] [Recon Reports Fiscal Year 2013 Financial Results BEIJING, September 30, 2013 /PRNewswire-Asia/ Recon Technology, Ltd (Nasdaq: RCON), an oilfield services provider that operates primarily in the People’s Republic of China (the “Company”), today announced increasing revenues and a generally improving operations in the fiscal year ended June 30, 2013. Fiscal Year 2013 Highlights ⋅ Total revenues due to continued]
SHI [SINOPEC SHANGHAI PETROCHEMICAL CO] CORRESP: (Original Filing)
[[SPC Letterhead] September 27, 2013 Mr. John Cash, Accounting Branch Chief Division of Corporation Finance 100 F Street, N.E. Re: Sinopec Shanghai Petrochemical Company Limited (the Company) Form 20-F for the Fiscal Year Ended December 31, 2012 Filed on April 30, 2013 File No. 1-12158 Dear Mr. Cash: 2012 20-F We are providing to you this letter in response to]
SHI [SINOPEC SHANGHAI PETROCHEMICAL CO] CORRESP: [SPC Letterhead] September 27, 2013 Mr. John Cash,
[[SPC Letterhead] September 27, 2013 Mr. John Cash, Accounting Branch Chief Division of Corporation Finance 100 F Street, N.E. Re: Sinopec Shanghai Petrochemical Company Limited (the Company) Form 20-F for the Fiscal Year Ended December 31, 2012 Filed on April 30, 2013 File No. 1-12158 Dear Mr. Cash: 2012 20-F We are providing to you this letter in response to]
CNIT [China Information Technology] 6-K: (Original Filing)
[EMPLOYEE INCENTIVE STOCK PURCHASE AGREEMENT EMPLOYEE INCENTIVE STOCK PURCHASE AGREEMENT ] This WHEREAS: 1. CHINA INFORMATION TECHNOLOGY, INC. is a company existing under the laws of the British Virgin Islands with registration number of 1718210 and listing on NASDAQ stock market (Stock symbol: CNIT). The Companys outstanding shares as of the Agreement date were 27,007,608 shares. 2. Party B is] [FORM 6-K CHINA INFORMATION TECHNOLOGY, INC. 21 st Floor, Everbright Bank Building Zhuzilin, Futian District Shenzhen, Guangdong, 518040 Note Note: On September 26, 2013, the Compensation Committee of China Information Technology, Inc. approved the grant of an aggregate of 3 million restricted shares (the Shares) under the Companys 2013 Equity Incentive Plan (the Plan) at a purchase price of $3.00]
TSM [TAIWAN SEMICONDUCTOR MANUFACTURING CO] 6-K: (Original Filing)
[Taiwan Semiconductor Manufacturing Company Ltd. By Lora Ho Senior Vice President & Chief Financial Officer TSMC Co-COO Dr. Shang-Yi Chiang to Retire Hsinchu, Taiwan, R.O.C. Sept. 27, 2013 - Dr. Chiang joined TSMC in 1997 and led TSMCs R&D team through five generations of technology, from 0.25 micron to 65nm. He first retired in 2006, but was invited by]
ATAI [ATA] 6-K: (Original Filing)
[ATA Announces Acquisition of Education Technology Company Xing Wei for US$3.19 Million, Appoints Mr. Cheng-Yaw Sun as New CEO and Director of ATA Mr. Kevin Ma to Remain on ATAs Board of Directors as Chairman ATA Inc. (ATA or the Company, Nasdaq: ATAI) Beijing, China, September 26, 2013 acquire Xing Wei Institute (HK) Limited (Xing Wei), a private education] [TABLE OF CONTENTS 2 ATA Inc.]
